Agioi Anargyroi; 3Rd Dept. of Medical Oncology

Athens 145 64

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Small Cell Lung Carcinoma

Studies at this site

• A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer — Completed
• A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) — Completed